Back to Search Start Over

Liver Disease in a Residential Cohort With Elevated Polychlorinated Biphenyl Exposures.

Authors :
Clair HB
Pinkston CM
Rai SN
Pavuk M
Dutton ND
Brock GN
Prough RA
Falkner KC
McClain CJ
Cave MC
Source :
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2018 Jul 01; Vol. 164 (1), pp. 39-49.
Publication Year :
2018

Abstract

Endocrine and metabolism disrupting chemicals (EDCs/MDCs) have been associated with environmental liver diseases including toxicant-associated steatohepatitis (TASH). TASH has previously been characterized by hepatocellular necrosis, disrupted intermediary metabolism, and liver inflammation. Polychlorinated biphenyls (PCBs) are environmental EDCs/MDCs associated with the genesis and progression of steatohepatitis in animal models and human liver injury in epidemiology studies. The cross-sectional Anniston Community Health Survey (ACHS) investigates ortho-substituted PCB exposures and health effects near a former PCB manufacturing complex. The rates of obesity, diabetes, and dyslipidemia were previously determined to be high in ACHS. In this study, 738 ACHS participants were categorized by liver disease status using the serum cytokeratin 18 biomarker. Associations between PCB exposures and mechanistic biomarkers of intermediary metabolism, inflammation, and hepatocyte death were determined. The liver disease prevalence was high (60.2%), and 80.7% of these individuals were categorized as having TASH. Sex and race/ethnicity differences were noted. TASH was associated with increased exposures to specific PCB congeners, insulin resistance, dyslipidemia, proinflammatory cytokines, and liver necrosis. These findings are consistent with PCB-related steatohepatitis. ΣPCBs was inversely associated with insulin resistance/production, leptin, and hepatocyte apoptosis, while other adipocytokines were increased. This is possibly the largest environmental liver disease study applying mechanistic biomarkers ever performed and the most comprehensive analysis of PCBs and adipocytokines. It provides insight into the mechanisms of PCB-related endocrine and metabolic disruption in liver disease and diabetes. In the future, associations between additional exposures and liver disease biomarkers will be evaluated in the ACHS and follow-up ACHS-II studies.

Details

Language :
English
ISSN :
1096-0929
Volume :
164
Issue :
1
Database :
MEDLINE
Journal :
Toxicological sciences : an official journal of the Society of Toxicology
Publication Type :
Academic Journal
Accession number :
29684222
Full Text :
https://doi.org/10.1093/toxsci/kfy076